Tags

Type your tag names separated by a space and hit enter

Quality of life among disease-free survivors of rectal cancer.
J Clin Oncol. 2004 Jan 15; 22(2):354-60.JC

Abstract

PURPOSE

To identify factors affecting the quality of life (QoL) of disease-free survivors of rectal cancer.

PATIENTS AND METHODS

One hundred twenty-one patients in complete remission more than 2 years after diagnosis were asked to complete three QoL questionnaires: the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30; its colorectal module, QLQ-CR38; and the Duke generic instrument.

RESULTS

Patients reported less pain (P =.002) than did controls drawn from the general population. EORTC QLQ-C30 physical scores were also higher among rectal cancer survivors than in the general Norwegian or German population (P =.0005 and P =.002, respectively). Unexpectedly, stoma patients reported better social functioning than did nonstoma patients (P =.005), with less anxiety (P =.008) and higher self-esteem (P =.0002). In the present authors' experience, the QLQ-CR38 does not discriminate between these groups. Residual abdominal or pelvic pain and constipation had the most negative influence on QoL.

CONCLUSION

QoL is high among rectal cancer survivors, including stoma patients. Simultaneous use of several QoL questionnaires appears to have value in follow-up and in monitoring the effects of therapy. The impact of residual pain and constipation on long-term QoL should be considered when establishing a treatment regimen.

Authors+Show Affiliations

Surgical Department and Medical Oncology, Centre Alexis Vautrin, 54511 Vandoeuvre lès Nancy, France. p.rauch@nancy.fnclcc.frNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

14722043

Citation

Rauch, Philippe, et al. "Quality of Life Among Disease-free Survivors of Rectal Cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 22, no. 2, 2004, pp. 354-60.
Rauch P, Miny J, Conroy T, et al. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol. 2004;22(2):354-60.
Rauch, P., Miny, J., Conroy, T., Neyton, L., & Guillemin, F. (2004). Quality of life among disease-free survivors of rectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 22(2), 354-60.
Rauch P, et al. Quality of Life Among Disease-free Survivors of Rectal Cancer. J Clin Oncol. 2004 Jan 15;22(2):354-60. PubMed PMID: 14722043.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Quality of life among disease-free survivors of rectal cancer. AU - Rauch,Philippe, AU - Miny,Joelle, AU - Conroy,Thierry, AU - Neyton,Lionel, AU - Guillemin,Francis, PY - 2004/1/15/pubmed PY - 2004/2/10/medline PY - 2004/1/15/entrez SP - 354 EP - 60 JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology JO - J. Clin. Oncol. VL - 22 IS - 2 N2 - PURPOSE: To identify factors affecting the quality of life (QoL) of disease-free survivors of rectal cancer. PATIENTS AND METHODS: One hundred twenty-one patients in complete remission more than 2 years after diagnosis were asked to complete three QoL questionnaires: the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30; its colorectal module, QLQ-CR38; and the Duke generic instrument. RESULTS: Patients reported less pain (P =.002) than did controls drawn from the general population. EORTC QLQ-C30 physical scores were also higher among rectal cancer survivors than in the general Norwegian or German population (P =.0005 and P =.002, respectively). Unexpectedly, stoma patients reported better social functioning than did nonstoma patients (P =.005), with less anxiety (P =.008) and higher self-esteem (P =.0002). In the present authors' experience, the QLQ-CR38 does not discriminate between these groups. Residual abdominal or pelvic pain and constipation had the most negative influence on QoL. CONCLUSION: QoL is high among rectal cancer survivors, including stoma patients. Simultaneous use of several QoL questionnaires appears to have value in follow-up and in monitoring the effects of therapy. The impact of residual pain and constipation on long-term QoL should be considered when establishing a treatment regimen. SN - 0732-183X UR - https://www.unboundmedicine.com/medline/citation/14722043/Quality_of_life_among_disease_free_survivors_of_rectal_cancer_ L2 - http://ascopubs.org/doi/full/10.1200/JCO.2004.03.137?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -